美《医学论坛报》第22卷第29期(1981年)第24页报道达拉斯消息:国际降血脂药物专题讨论会于1981年冬在达拉斯召开。塔夫茨大学医学院院长利维(Robert I Levy)博士任主席。利维在开幕词中谈到为高血脂病人选用适当降脂药物问题,认为现在已有的降血脂药物,有几种是美国医生所熟悉的,但其中至少有一种对医生是新的。每种药物均有其特异的生化作用,从而引起病人血脂过高的代谢失调有许 The Medical Tribune Vol. 22, No. 29 (1981) p. 24 Reporting Dallas News: The International Lipid-lowering Medications Symposium was held in Dallas in the winter of 1981. Dr. Robert I Levy, Dean of the Tufts University School of Medicine, chaired the session. In his opening speech, Levy talked about the issue of choosing appropriate lipid-lowering drugs for hyperlipidemic patients. He believes that there are several lipid-lowering drugs currently available to the American physician, but at least one of them is new to doctors. Each drug has its own specific biochemical effects, which can cause the patients with hyperlipidemia and metabolic disorders